Rasagiline

Rasagiline is used alone or in combination with another medication to treat the symptoms of Parkinson's disease (a slowly progressing disease of the nervous system causing a fixed face without expression, tremor at rest, slowing of movements, walking with shuffling steps, stooped posture and muscle weakness). Rasagiline is in a class of medications called monoamine oxidase (MAO) type B inhibitors. It works by increasing the amounts of certain natural substances in the brain.

Rasagiline comes as a tablet to take by mouth. It is usually taken once a day with or without food. Take rasagiline at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take rasagiline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor may start you on a low dose of rasagiline and may increase your dose based upon your body's response to this medication.

Do not stop taking rasagiline without talking to your doctor. Your doctor will probably decrease your dose gradually. If you suddenly stop taking rasagiline, you may experience withdrawal symptoms such as a fever; muscle stiffness; unsteadiness, wobbliness, or lack of coordination; or changes in consciousness. Tell your doctor if you experience any of these symptoms when your dose of rasagiline is decreased.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking rasagiline,

• tell your doctor and pharmacist if you are allergic to rasagiline, any other medications, or any of the ingredients in rasagiline tablets. Ask your pharmacist for a list of the ingredients.

• tell your doctor if you are taking cough and cold products containing dextromethorphan (DM; Delsym, Hold, Robitussin CoughGels, Vicks 44 Cough Relief, in Robitussin DM, others), cyclobenzaprine (Flexeril), meperidine (Demerol), methadone (Dolophine, Methadose), propoxyphene (Darvon, in Darvocet-N, others), St. John's wort, or tramadol (Ultram, in Ultracet). Also tell your doctor if you are taking MAO inhibitors such as phenelzine (Nardil), selegiline (Eldepryl), or tranylcypromine (Parnate) or have stopped taking them within the past two weeks. Your doctor may tell you not to take rasagiline if you are taking one or more of these medications.

• tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: amphetamines (Adderall, Dexedrine, DextroStat); antidepressants; cimetidine (Tagamet); decongestants placed in the eye or nose; diet or weight-control products containing ephedrine; fluoroquinolone antibiotics including ciprofloxacin (Cipro), gatifloxacin (Tequin), levofloxacin (Levaquin), norfloxacin (Noroxin), and ofloxacin (Floxin); fluvoxamine (Luvox); medications to treat asthma; medications to treat high blood pressure; medications to treat mental illness; medications to treat pain; phenylpropanolamine (not available in the U.S.); pseudoephedrine (PediaCare, Sudafed, Suphedrine, others); and ticlopidine (Ticlid). Tell your doctor if you are taking fluoxetine (Prozac, Sarafem) or have stopped taking it within the past 5 weeks. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

• tell your doctor if you have or have ever had high blood pressure, mental illness or psychosis;kidney, or liver disease.

• tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking rasagiline, call your doctor.

• you should know that rasagiline may cause dizziness, lightheadedness, nausea, sweating, and fainting when you get up too quickly from a lying position. This is more common during the first 2 months of taking rasagiline. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.

• you should know that rasagiline may cause serious, life-threatening high blood pressure when taken with certain medications or foods. Carefully follow your doctor's instructions about medications and foods to be avoided. Call your doctor right away if you have a severe headache, blurred vision, or any of the other symptoms listed below as serious side effects.

• you should know that people who have Parkinson's disease have a higher risk of melanoma (a type of skin cancer) than people who do not have Parkinson's disease. It is not known whether this increased risk is caused by Parkinson's disease, medications used for Parkinson's disease such as rasagiline, or other factors. You should have regular visits with a dermatologist to examine your skin for melanoma.

• you should know that some people who took rasagiline or similar medications to treat Parkinson's disease experienced intense urges to gamble, increased sexual urges, and other urges that they were unable to control. Tell your doctor if you experience new or increased gambling urges, increased sexual urges, or other intense urges while taking rasagiline.

You will need to avoid eating foods that contain very high amounts of tyramine, such as aged cheeses (e.g., Stilton or blue cheese) during your treatment with rasagiline. Talk to your doctor or dietitian about which foods you should avoid during your treatment or if you do not feel well after eating or drinking certain foods while taking rasagiline.

Do not take a double dose to make up for a missed one. Skip the missed dose and take your next dose at the usual time the next day.

• Rasagiline may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • mild headache

  • joint or neck pain

  • heartburn

  • nausea

  • vomiting

  • stomach pain

  • constipation

  • diarrhea

  • loss of appetite

  • weight loss

  • flu-like symptoms

  • fever

  • sweating

  • red, swollen, and/or itchy eyes

  • dry mouth

  • swollen gums

  • unsteadiness, wobbliness, or lack of coordination

  • involuntary, repeated body movements

  • lack of energy

  • sleepiness

  • abnormal dreams

  • depression

  • pain, burning, numbness, or tingling in the hands or feet

  • rash

  • bruising or purple discoloration on skin

• Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

  • severe headache

  • blurred vision

  • seizures

  • chest pain

  • shortness of breath or difficulty breathing

  • confusion

  • unconsciousness

  • slow or difficult speech

  • dizziness or faintness

  • weakness or numbness of an arm or leg

  • hallucinating (seeing things or hearing voices that do not exist)

  • extreme restlessness

  • difficulty thinking clearly or understanding reality

• Rasagiline may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of rasagiline overdose may occur as late as 1 to 2 days after the overdose. Symptoms of overdose may include the following:

• drowsiness

• dizziness

• faintness

• irritability

• hyperactivity

• agitation or restlessness

• severe headache

• hallucinating

• confusion

• loss of coordination

• difficulty opening the mouth

• rigid body spasm that may include an arched back

• twitching muscles

• seizures

• loss of consciousness

• fast or irregular heart beat

• pain in the area between the stomach and chest

• difficulty breathing or slowed breathing

• diarrhea

• fever

• sweating

• cool, clammy skin

• shivering

• increase in pupil size (black circle in middle of eye)

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug	Interaction
Moxifloxacin	Moxifloxacin The metabolism of Rasagiline can be decreased when combined with Moxifloxacin.
Repaglinide	Repaglinide Rasagiline may increase the hypoglycemic activities of Repaglinide.
Insulin Glargine (rDNA origin) Injection	Insulin Glargine (rDNA origin) Injection The metabolism of Rasagiline can be increased when combined with Insulin glargine.
Leflunomide	Leflunomide The serum concentration of Rasagiline can be decreased when it is combined with Leflunomide.
Nevirapine	Nevirapine The metabolism of Rasagiline can be decreased when combined with Nevirapine.
Dolasetron	Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Rasagiline.
Aminophylline	Aminophylline The metabolism of Rasagiline can be decreased when combined with Aminophylline.
Anagrelide	Anagrelide The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Anagrelide.
Candesartan	Candesartan Rasagiline may increase the hypotensive activities of Candesartan.
Cilostazol	Cilostazol The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Cilostazol.
Clopidogrel	Clopidogrel The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Clopidogrel.
Diphenoxylate	Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Rasagiline.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) The metabolism of Rasagiline can be decreased when combined with Conjugated estrogens.
Fenofibrate	Fenofibrate Fenofibrate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Guanfacine	Guanfacine Rasagiline may increase the hypotensive activities of Guanfacine.
Magnesium Hydroxide	Magnesium Hydroxide Rasagiline may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine	Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Rasagiline.
Miglitol	Miglitol Rasagiline may increase the hypoglycemic activities of Miglitol.
Mycophenolate	Mycophenolate Mycophenolic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Naratriptan	Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Rasagiline.
Olsalazine	Olsalazine Olsalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Paregoric	Paregoric Rasagiline may increase the analgesic activities of Morphine.
Penbutolol	Penbutolol Rasagiline may increase the hypotensive activities of Acebutolol.
Pentazocine	Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Rasagiline.
Potassium	Potassium Potassium cation may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone	Prednisone Prednisone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ranitidine	Ranitidine The metabolism of Rasagiline can be decreased when combined with Ranitidine.
Reserpine	Reserpine The risk or severity of adverse effects can be increased when Rasagiline is combined with Reserpine.
Rizatriptan	Rizatriptan The metabolism of Rizatriptan can be decreased when combined with Rasagiline.
Sumatriptan	Sumatriptan The metabolism of Sumatriptan can be decreased when combined with Rasagiline.
Tacrolimus	Tacrolimus Tacrolimus may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tizanidine	Tizanidine Rasagiline may increase the orthostatic hypotensive activities of Tizanidine.
Zolmitriptan	Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Rasagiline.
Ampicillin Injection	Ampicillin Injection Ampicillin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Doxycycline Injection	Doxycycline Injection Doxycycline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Famotidine Injection	Famotidine Injection The metabolism of Rasagiline can be decreased when combined with Famotidine.
Fluconazole Injection	Fluconazole Injection Fluconazole may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Foscarnet Injection	Foscarnet Injection Foscarnet may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Hydromorphone Injection	Hydromorphone Injection Rasagiline may increase the serotonergic activities of Hydromorphone.
Interferon Beta-1b Injection	Interferon Beta-1b Injection The metabolism of Rasagiline can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection	Interferon Gamma-1b Injection The metabolism of Rasagiline can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection	Levofloxacin Injection The metabolism of Rasagiline can be decreased when combined with Levofloxacin.
Meperidine Injection	Meperidine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Rasagiline is combined with Meperidine.
Metoclopramide Injection	Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Rasagiline.
Morphine Injection	Morphine Injection Rasagiline may increase the analgesic activities of Morphine.
Pamidronate Injection	Pamidronate Injection Pamidronic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Vancomycin Injection	Vancomycin Injection Rasagiline may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine	Altretamine Rasagiline may increase the hypertensive activities of Amphetamine.
Cefuroxime	Cefuroxime Cefuroxime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cyclosporine	Cyclosporine Cyclosporine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ondansetron	Ondansetron The metabolism of Rasagiline can be decreased when combined with Ondansetron.
Enoxaparin Injection	Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Enoxaparin.
Granisetron	Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Rasagiline.
Torsemide	Torsemide Rasagiline may increase the hypotensive activities of Torasemide.
Olanzapine	Olanzapine The metabolism of Rasagiline can be decreased when combined with Olanzapine.
Alosetron	Alosetron The metabolism of Rasagiline can be decreased when combined with Alosetron.
Entacapone	Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Rasagiline.
Eprosartan	Eprosartan Rasagiline may increase the hypotensive activities of Eprosartan.
Meloxicam	Meloxicam Meloxicam may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Oxcarbazepine	Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Rasagiline.
Pantoprazole	Pantoprazole Pantoprazole may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Telmisartan	Telmisartan Rasagiline may increase the hypotensive activities of Telmisartan.
Temozolomide	Temozolomide Temozolomide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Zaleplon	Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Anakinra	Anakinra The metabolism of Rasagiline can be increased when combined with Anakinra.
Desloratadine	Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Rasagiline.
Linezolid	Linezolid The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Linezolid.
Pentosan Polysulfate	Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Pentosan polysulfate.
Trimipramine	Trimipramine Rasagiline may increase the serotonergic activities of Trimipramine.
Etanercept Injection	Etanercept Injection The metabolism of Rasagiline can be increased when combined with Etanercept.
Glycopyrrolate	Glycopyrrolate Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil	Modafinil The metabolism of Rasagiline can be increased when combined with Modafinil.
Perindopril	Perindopril Rasagiline may increase the hypotensive activities of Perindopril.
Tenofovir	Tenofovir Tenofovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dutasteride	Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Rasagiline.
Epinephrine Injection	Epinephrine Injection Rasagiline may increase the hypertensive activities of Epinephrine.
Eplerenone	Eplerenone Rasagiline may increase the orthostatic hypotensive activities of Eplerenone.
Escitalopram	Escitalopram The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Escitalopram.
Olmesartan	Olmesartan Rasagiline may increase the hypotensive activities of Olmesartan.
Zonisamide	Zonisamide Zonisamide may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection	Adalimumab Injection The metabolism of Rasagiline can be increased when combined with Adalimumab.
Aripiprazole	Aripiprazole The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Aripiprazole.
Atomoxetine	Atomoxetine The risk or severity of adverse effects can be increased when Rasagiline is combined with Atomoxetine.
Dexmethylphenidate	Dexmethylphenidate Rasagiline may increase the hypertensive activities of Dexmethylphenidate.
Atazanavir	Atazanavir Atazanavir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Almotriptan	Almotriptan The metabolism of Almotriptan can be decreased when combined with Rasagiline.
Eletriptan	Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Rasagiline.
Vardenafil	Vardenafil The risk or severity of hypotension can be increased when Vardenafil is combined with Rasagiline.
Emtricitabine	Emtricitabine Emtricitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection	Interferon Beta-1a Subcutaneous Injection The metabolism of Rasagiline can be decreased when combined with Interferon beta-1a.
Memantine	Memantine Memantine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tegaserod	Tegaserod The metabolism of Rasagiline can be decreased when combined with Tegaserod.
Tadalafil	Tadalafil Tadalafil may increase the hypotensive activities of Rasagiline.
Frovatriptan	Frovatriptan The metabolism of Rasagiline can be decreased when combined with Frovatriptan.
Gemifloxacin	Gemifloxacin The metabolism of Rasagiline can be decreased when combined with Gemifloxacin.
Apomorphine Injection	Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Rasagiline.
Infliximab Injection	Infliximab Injection The metabolism of Rasagiline can be increased when combined with Infliximab.
Protriptyline	Protriptyline Rasagiline may increase the serotonergic activities of Protriptyline.
Duloxetine	Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Rasagiline is combined with Duloxetine.
Tinidazole	Tinidazole Tinidazole may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Trospium	Trospium Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan	Bosentan Rasagiline may increase the hypotensive activities of Bosentan.
Cefditoren	Cefditoren Cefdinir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cinacalcet	Cinacalcet The metabolism of Rasagiline can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection	Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Erlotinib	Erlotinib The metabolism of Rasagiline can be decreased when combined with Erlotinib.
Eszopiclone	Eszopiclone The risk or severity of CNS depression can be increased when Rasagiline is combined with Eszopiclone.
Ganciclovir	Ganciclovir Ganciclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection	Insulin Aspart (rDNA Origin) Injection Rasagiline may increase the hypoglycemic activities of Insulin aspart.
Ribavirin	Ribavirin Ribavirin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Solifenacin	Solifenacin Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Valganciclovir	Valganciclovir Rasagiline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Adefovir	Adefovir Adefovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dextroamphetamine	Dextroamphetamine Rasagiline may increase the hypertensive activities of Amphetamine.
Entecavir	Entecavir The metabolism of Rasagiline can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection	Peginterferon Alfa-2a Injection The metabolism of Rasagiline can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron)	Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Rasagiline can be increased when it is combined with Peginterferon alfa-2b.
Pramlintide Injection	Pramlintide Injection Rasagiline may increase the hypoglycemic activities of Pramlintide.
Sodium Oxybate	Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Exenatide Injection	Exenatide Injection Rasagiline may increase the hypoglycemic activities of Exenatide.
Isocarboxazid	Isocarboxazid The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Rasagiline.
Ramelteon	Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Rasagiline.
Darifenacin	Darifenacin Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl	Fentanyl The risk or severity of adverse effects can be increased when Rasagiline is combined with Fentanyl.
Pregabalin	Pregabalin The therapeutic efficacy of Rasagiline can be increased when used in combination with Pregabalin.
Deferasirox	Deferasirox The serum concentration of Rasagiline can be increased when it is combined with Deferasirox.
Phenylephrine	Phenylephrine Rasagiline may increase the hypertensive activities of Phenylephrine.
Felbamate	Felbamate The risk or severity of adverse effects can be increased when Felbamate is combined with Rasagiline.
Insulin Detemir (rDNA Origin) Injection	Insulin Detemir (rDNA Origin) Injection Rasagiline may increase the hypoglycemic activities of Insulin detemir.
Ranolazine	Ranolazine Ranolazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Abatacept Injection	Abatacept Injection The metabolism of Rasagiline can be increased when combined with Abatacept.
Imatinib	Imatinib The metabolism of Rasagiline can be decreased when combined with Imatinib.
Sitagliptin	Sitagliptin Sitagliptin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Varenicline	Varenicline Varenicline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Albuterol	Albuterol Salbutamol may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Paliperidone	Paliperidone The risk or severity of adverse effects can be increased when Paliperidone is combined with Rasagiline.
Bortezomib	Bortezomib The metabolism of Rasagiline can be decreased when combined with Bortezomib.
Clofarabine Injection	Clofarabine Injection Rasagiline may increase the orthostatic hypotensive activities of Clofarabine.
Insulin Glulisine (rDNA origin) Injection	Insulin Glulisine (rDNA origin) Injection The metabolism of Rasagiline can be increased when combined with Insulin glulisine.
Lubiprostone	Lubiprostone Lubiprostone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Primaquine	Primaquine The metabolism of Rasagiline can be decreased when combined with Primaquine.
Aliskiren	Aliskiren Rasagiline may increase the hypotensive activities of Aliskiren.
Pemetrexed Injection	Pemetrexed Injection Rasagiline may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate	Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Rasagiline.
Lisdexamfetamine	Lisdexamfetamine Rasagiline may increase the hypertensive activities of Lisdexamfetamine.
Nabilone	Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Sorafenib	Sorafenib The metabolism of Rasagiline can be decreased when combined with Sorafenib.
Sunitinib	Sunitinib Rasagiline may increase the hypoglycemic activities of Sunitinib.
Dronabinol	Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Levocetirizine	Levocetirizine The risk or severity of adverse effects can be increased when Rasagiline is combined with Levocetirizine.
Pegaptanib Injection	Pegaptanib Injection Rasagiline may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib	Dasatinib The metabolism of Rasagiline can be decreased when combined with Dasatinib.
Mexiletine	Mexiletine The metabolism of Rasagiline can be decreased when combined with Mexiletine.
Armodafinil	Armodafinil The metabolism of Rasagiline can be increased when combined with Armodafinil.
Azacitidine Injection	Azacitidine Injection Azacitidine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Lenalidomide	Lenalidomide Lenalidomide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Budesonide	Budesonide Budesonide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Desmopressin	Desmopressin Desmopressin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
OnabotulinumtoxinA Injection	OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Rasagiline.
RimabotulinumtoxinB Injection	RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rasagiline.
Doripenem Injection	Doripenem Injection Rasagiline may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection	Arsenic Trioxide Injection Rasagiline may increase the orthostatic hypotensive activities of Arsenic trioxide.
Desvenlafaxine	Desvenlafaxine Rasagiline may increase the serotonergic activities of Desvenlafaxine.
Cevimeline	Cevimeline Cevimeline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nebivolol	Nebivolol Rasagiline may increase the hypotensive activities of Nebivolol.
Tretinoin	Tretinoin Rasagiline may increase the orthostatic hypotensive activities of Tretinoin.
Bendamustine Injection	Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Rasagiline.
Flecainide	Flecainide The metabolism of Rasagiline can be decreased when combined with Flecainide.
Certolizumab Injection	Certolizumab Injection The metabolism of Rasagiline can be increased when combined with Certolizumab pegol.
Daptomycin Injection	Daptomycin Injection Daptomycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Praziquantel	Praziquantel The metabolism of Rasagiline can be decreased when combined with Praziquantel.
Methylnaltrexone Injection	Methylnaltrexone Injection Rasagiline may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide	Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Rasagiline.
Midazolam	Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Rasagiline.
Naltrexone Injection	Naltrexone Injection The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Rasagiline.
Dexrazoxane Injection	Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Eltrombopag	Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Rasagiline.
Milnacipran	Milnacipran Rasagiline may increase the serotonergic activities of Milnacipran.
Plerixafor Injection	Plerixafor Injection Rasagiline may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine	Fesoterodine Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Betaxolol	Betaxolol Rasagiline may increase the hypotensive activities of Betaxolol.
Iloperidone	Iloperidone The therapeutic efficacy of Rasagiline can be decreased when used in combination with Iloperidone.
Prasugrel	Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Prasugrel.
Lacosamide	Lacosamide The risk or severity of adverse effects can be increased when Rasagiline is combined with Lacosamide.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone	Dronedarone The risk or severity of hypertension can be increased when Rasagiline is combined with Dronedarone.
AbobotulinumtoxinA Injection	AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Rasagiline.
Pralatrexate Injection	Pralatrexate Injection Rasagiline may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection	Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Rasagiline.
Saxagliptin	Saxagliptin Rasagiline may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection	Telavancin Injection Rasagiline may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tapentadol	Tapentadol The risk or severity of adverse effects can be increased when Tapentadol is combined with Rasagiline.
Topotecan	Topotecan Topotecan may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Golimumab Injection	Golimumab Injection The metabolism of Rasagiline can be increased when combined with Golimumab.
Pazopanib	Pazopanib The metabolism of Pazopanib can be decreased when combined with Rasagiline.
Asenapine	Asenapine The metabolism of Asenapine can be decreased when combined with Rasagiline.
Vigabatrin	Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Rasagiline.
Albendazole	Albendazole The metabolism of Rasagiline can be decreased when combined with Albendazole.
Oxymorphone	Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Rasagiline.
Dabigatran	Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Dabigatran.
Liraglutide Injection	Liraglutide Injection Rasagiline may increase the hypoglycemic activities of Liraglutide.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Rasagiline can be increased when combined with Tocilizumab.
Dalfampridine	Dalfampridine The risk or severity of seizure can be increased when Rasagiline is combined with Dalfampridine.
IncobotulinumtoxinA Injection	IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Rasagiline.
Ceftaroline Injection	Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Lurasidone	Lurasidone The therapeutic efficacy of Rasagiline can be decreased when used in combination with Lurasidone.
Acetaminophen Injection	Acetaminophen Injection The metabolism of Rasagiline can be decreased when combined with Acetaminophen.
Vilazodone	Vilazodone The metabolism of Vilazodone can be decreased when combined with Rasagiline.
Ipilimumab Injection	Ipilimumab Injection Rasagiline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection	Denileukin Diftitox Injection Rasagiline may increase the orthostatic hypotensive activities of Aldesleukin.
Terbutaline Injection	Terbutaline Injection Terbutaline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Azilsartan	Azilsartan Rasagiline may increase the orthostatic hypotensive activities of Azilsartan medoxomil.
Roflumilast	Roflumilast Rasagiline may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin	Linagliptin Rasagiline may increase the hypoglycemic activities of Linagliptin.
Abiraterone	Abiraterone The serum concentration of Rasagiline can be increased when it is combined with Abiraterone.
Rivaroxaban	Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Rivaroxaban.
Ticagrelor	Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Ticagrelor.
Ruxolitinib	Ruxolitinib Rasagiline may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam	Clobazam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Clobazam.
Vemurafenib	Vemurafenib The serum concentration of Rasagiline can be increased when it is combined with Vemurafenib.
Deferiprone	Deferiprone Rasagiline may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib	Axitinib The metabolism of Axitinib can be decreased when combined with Rasagiline.
Cabergoline	Cabergoline The metabolism of Cabergoline can be decreased when combined with Rasagiline.
Naloxone Injection	Naloxone Injection Naloxone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ambrisentan	Ambrisentan Rasagiline may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection	Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Fondaparinux.
Ezogabine	Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Rasagiline.
Iloprost	Iloprost Rasagiline may increase the orthostatic hypotensive activities of Iloprost.
Enzalutamide	Enzalutamide Rasagiline may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron	Mirabegron Rasagiline may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Teriflunomide	Teriflunomide The serum concentration of Rasagiline can be decreased when it is combined with Teriflunomide.
Lorcaserin	Lorcaserin Rasagiline may increase the hypoglycemic activities of Mecasermin.
Teduglutide Injection	Teduglutide Injection Rasagiline may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Icosapent Ethyl	Icosapent Ethyl The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Icosapent ethyl.
Alogliptin	Alogliptin Rasagiline may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide	Pomalidomide The risk or severity of adverse effects can be increased when Rasagiline is combined with Pomalidomide.
Apixaban	Apixaban The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Apixaban.
Canagliflozin	Canagliflozin Rasagiline may increase the orthostatic hypotensive activities of Canagliflozin.
Methazolamide	Methazolamide Rasagiline may increase the orthostatic hypotensive activities of Methazolamide.
Trametinib	Trametinib Rasagiline may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran	Levomilnacipran Rasagiline may increase the serotonergic activities of Levomilnacipran.
Ertapenem Injection	Ertapenem Injection Ertapenem may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Vortioxetine	Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Rasagiline.
Perampanel	Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Avanafil	Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Rasagiline.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Obinutuzumab Injection	Obinutuzumab Injection Rasagiline may increase the orthostatic hypotensive activities of Obinutuzumab.
Simeprevir	Simeprevir The metabolism of Rasagiline can be decreased when combined with Simeprevir.
Sofosbuvir	Sofosbuvir Rasagiline may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin	Dapagliflozin Rasagiline may increase the orthostatic hypotensive activities of Dapagliflozin.
Apremilast	Apremilast The metabolism of Rasagiline can be increased when combined with Apremilast.
Droxidopa	Droxidopa Rasagiline may increase the hypertensive activities of Droxidopa.
Siltuximab Injection	Siltuximab Injection The metabolism of Rasagiline can be increased when combined with Siltuximab.
Albiglutide Injection	Albiglutide Injection Rasagiline may increase the hypoglycemic activities of Albiglutide.
Eslicarbazepine	Eslicarbazepine The risk or severity of adverse effects can be increased when Rasagiline is combined with Eslicarbazepine.
Belinostat Injection	Belinostat Injection The metabolism of Rasagiline can be increased when combined with Belinostat.
Testosterone Injection	Testosterone Injection Testosterone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Empagliflozin	Empagliflozin Rasagiline may increase the orthostatic hypotensive activities of Empagliflozin.
Vorapaxar	Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Vorapaxar.
Hydrocodone	Hydrocodone Rasagiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant	Suvorexant Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection	Dulaglutide Injection Rasagiline may increase the hypoglycemic activities of Dulaglutide.
Edoxaban	Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Edoxaban.
Peginterferon Beta-1a Injection	Peginterferon Beta-1a Injection The metabolism of Rasagiline can be decreased when combined with Peginterferon beta-1a.
Methamphetamine	Methamphetamine Rasagiline may increase the hypertensive activities of Metamfetamine.
Tasimelteon	Tasimelteon The risk or severity of adverse effects can be increased when Rasagiline is combined with Tasimelteon.
Riociguat	Riociguat Rasagiline may increase the hypotensive activities of Riociguat.
Pirfenidone	Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Rasagiline.
Secukinumab Injection	Secukinumab Injection The metabolism of Rasagiline can be increased when combined with Secukinumab.
Risperidone Injection	Risperidone Injection Rasagiline may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation	Insulin Human Inhalation The metabolism of Rasagiline can be increased when combined with Insulin human.
Lenvatinib	Lenvatinib The metabolism of Rasagiline can be decreased when combined with Lenvatinib.
Dinutuximab Injection	Dinutuximab Injection Rasagiline may increase the orthostatic hypotensive activities of Dinutuximab.
Haloperidol Injection	Haloperidol Injection The risk or severity of CNS depression can be increased when Rasagiline is combined with Haloperidol.
Amiloride	Amiloride Rasagiline may increase the orthostatic hypotensive activities of Amiloride.
Macitentan	Macitentan Rasagiline may increase the hypotensive activities of Macitentan.
Flibanserin	Flibanserin The metabolism of Flibanserin can be decreased when combined with Rasagiline.
Brexpiprazole	Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Rasagiline.
Ziprasidone Injection	Ziprasidone Injection The risk or severity of adverse effects can be increased when Rasagiline is combined with Ziprasidone.
Cariprazine	Cariprazine The metabolism of Cariprazine can be decreased when combined with Rasagiline.
Penicillin G Procaine Injection	Penicillin G Procaine Injection Rasagiline may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline	Eluxadoline The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection	Insulin Degludec (rDNA Origin) Injection The metabolism of Rasagiline can be increased when combined with Insulin degludec.
Osimertinib	Osimertinib The serum concentration of Rasagiline can be decreased when it is combined with Osimertinib.
Ixazomib	Ixazomib Rasagiline may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad	Lesinurad Rasagiline may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection Rasagiline may increase the orthostatic hypotensive activities of Amphotericin B.
Defibrotide Injection	Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Defibrotide.
Brivaracetam Injection	Brivaracetam Injection The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Rasagiline.
Midodrine	Midodrine Rasagiline may increase the hypertensive activities of Midodrine.
Selexipag	Selexipag Rasagiline may increase the hypotensive activities of Selexipag.
Pimavanserin	Pimavanserin The therapeutic efficacy of Rasagiline can be decreased when used in combination with Pimavanserin.
Obeticholic Acid	Obeticholic Acid The metabolism of Rasagiline can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection	Diphenhydramine Injection The risk or severity of adverse effects can be increased when Rasagiline is combined with Diphenhydramine.
Furosemide Injection	Furosemide Injection Rasagiline may increase the orthostatic hypotensive activities of Furosemide.
Rucaparib	Rucaparib The metabolism of Rucaparib can be decreased when combined with Rasagiline.
Lixisenatide Injection	Lixisenatide Injection Rasagiline may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia)	Doxepin (Insomnia) Rasagiline may increase the serotonergic activities of Doxepin.
Deutetrabenazine	Deutetrabenazine The risk or severity of adverse effects can be increased when Rasagiline is combined with Deutetrabenazine.
Valbenazine	Valbenazine Rasagiline may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Safinamide	Safinamide The risk or severity of adverse effects can be increased when Rasagiline is combined with Safinamide.
Naldemedine	Naldemedine Rasagiline may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin	Midostaurin The serum concentration of Rasagiline can be increased when it is combined with Midostaurin.
Enasidenib	Enasidenib The metabolism of Rasagiline can be decreased when combined with Enasidenib.
Benznidazole	Benznidazole Rasagiline may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin	Delafloxacin Rasagiline may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Betrixaban	Betrixaban The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Betrixaban.
Semaglutide Injection	Semaglutide Injection Rasagiline may increase the hypoglycemic activities of Semaglutide.
Tetrabenazine	Tetrabenazine The risk or severity of adverse effects can be increased when Rasagiline is combined with Tetrabenazine.
Ertugliflozin	Ertugliflozin Ertugliflozin may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection	Buprenorphine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Buprenorphine is combined with Rasagiline.
Apalutamide	Apalutamide Rasagiline may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Fostamatinib	Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Rasagiline.
Baricitinib	Baricitinib Rasagiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine	Lofexidine The therapeutic efficacy of Rasagiline can be increased when used in combination with Lofexidine.
Plazomicin Injection	Plazomicin Injection Rasagiline may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Binimetinib	Binimetinib The metabolism of Binimetinib can be decreased when combined with Rasagiline.
Cannabidiol	Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rasagiline.
Stiripentol	Stiripentol The metabolism of Rasagiline can be decreased when combined with Stiripentol.
Gilteritinib	Gilteritinib The therapeutic efficacy of Rasagiline can be decreased when used in combination with Gilteritinib.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection Rasagiline may increase the orthostatic hypotensive activities of Paclitaxel.
Rifamycin	Rifamycin The metabolism of Rasagiline can be decreased when combined with Rifamycin.
Prucalopride	Prucalopride Rasagiline may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Rasagiline can be increased when combined with Emapalumab.
Siponimod	Siponimod The risk or severity of hypertension can be increased when Rasagiline is combined with Siponimod.
Acyclovir Ophthalmic	Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Caplacizumab-yhdp Injection	Caplacizumab-yhdp Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Caplacizumab.
Brexanolone Injection	Brexanolone Injection The risk or severity of adverse effects can be increased when Rasagiline is combined with Brexanolone.
Solriamfetol	Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Rasagiline.
Triclabendazole	Triclabendazole The metabolism of Rasagiline can be decreased when combined with Triclabendazole.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Rasagiline.
Pitolisant	Pitolisant The metabolism of Pitolisant can be increased when combined with Rasagiline.
Phenytoin Injection	Phenytoin Injection The risk or severity of adverse effects can be increased when Phenytoin is combined with Rasagiline.
Fosphenytoin Injection	Fosphenytoin Injection The metabolism of Rasagiline can be increased when combined with Fosphenytoin.
Lumateperone	Lumateperone The therapeutic efficacy of Rasagiline can be decreased when used in combination with Lumateperone.
Lasmiditan	Lasmiditan The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Lasmiditan.
Cenobamate	Cenobamate The therapeutic efficacy of Cenobamate can be decreased when used in combination with Rasagiline.
Selumetinib	Selumetinib The metabolism of Selumetinib can be decreased when combined with Rasagiline.
Selpercatinib	Selpercatinib The risk or severity of hypertension can be increased when Rasagiline is combined with Selpercatinib.
Capmatinib	Capmatinib The metabolism of Rasagiline can be decreased when combined with Capmatinib.
Lemborexant	Lemborexant The risk or severity of adverse effects can be increased when Rasagiline is combined with Lemborexant.
Fenfluramine	Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Rasagiline.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Rasagiline can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection	Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Rasagiline is combined with Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine	Viloxazine The risk or severity of adverse effects can be increased when Rasagiline is combined with Viloxazine.
Tobramycin Injection	Tobramycin Injection Tobramycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Theophylline	Theophylline The metabolism of Rasagiline can be decreased when combined with Theophylline.
Fenoprofen	Fenoprofen Fenoprofen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Indomethacin	Indomethacin Indomethacin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Naproxen	Naproxen Naproxen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tolmetin	Tolmetin Tolmetin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sulindac	Sulindac Sulindac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Trazodone	Trazodone Rasagiline may increase the serotonergic activities of Trazodone.
Isotretinoin	Isotretinoin Isotretinoin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sucralfate	Sucralfate Sucralfate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Floxuridine	Floxuridine Floxuridine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Phenobarbital	Phenobarbital The risk or severity of adverse effects can be increased when Phenobarbital is combined with Rasagiline.
Metaxalone	Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Rasagiline.
Methotrexate Injection	Methotrexate Injection Methotrexate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Levorphanol	Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Rasagiline.
Primidone	Primidone The metabolism of Rasagiline can be increased when combined with Primidone.
Methsuximide	Methsuximide The risk or severity of adverse effects can be increased when Rasagiline is combined with Methsuximide.
Diethylpropion	Diethylpropion The risk or severity of adverse effects can be increased when Rasagiline is combined with Diethylpropion.
Chlorpromazine	Chlorpromazine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Chlorpromazine.
Diazepam	Diazepam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Diazepam.
Oxazepam	Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Rasagiline.
Flurazepam	Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Rasagiline.
Clorazepate	Clorazepate The therapeutic efficacy of Rasagiline can be decreased when used in combination with Clorazepic acid.
Lorazepam	Lorazepam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Lorazepam.
Phenoxybenzamine	Phenoxybenzamine Rasagiline may increase the hypotensive activities of Phenoxybenzamine.
Carmustine	Carmustine The metabolism of Rasagiline can be decreased when combined with Carmustine.
Amantadine	Amantadine The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Rasagiline.
Codeine	Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Rasagiline.
Meprobamate	Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Rasagiline.
Chlordiazepoxide	Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Rasagiline.
Bromocriptine	Bromocriptine Rasagiline may increase the hypertensive activities of Bromocriptine.
Metaproterenol	Metaproterenol The risk or severity of adverse effects can be increased when Rasagiline is combined with Orciprenaline.
Tranylcypromine	Tranylcypromine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Rasagiline.
Phenelzine	Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Rasagiline.
Procarbazine	Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Rasagiline.
Ergoloid Mesylates	Ergoloid Mesylates The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Rasagiline.
Tetracycline	Tetracycline Tetracycline may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Minocycline	Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Prochlorperazine	Prochlorperazine The therapeutic efficacy of Prochlorperazine can be decreased when used in combination with Rasagiline.
Thioridazine	Thioridazine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Thioridazine.
Trifluoperazine	Trifluoperazine The therapeutic efficacy of Trifluoperazine can be decreased when used in combination with Rasagiline.
Bleomycin	Bleomycin Bleomycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sulfadiazine	Sulfadiazine Sulfadiazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Oxycodone	Oxycodone Rasagiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.
Methadone	Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Rasagiline.
Oxybutynin	Oxybutynin Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine	Benztropine Benzatropine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Maprotiline	Maprotiline The risk or severity of adverse effects can be increased when Rasagiline is combined with Maprotiline.
Ibuprofen	Ibuprofen Ibuprofen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Trihexyphenidyl	Trihexyphenidyl Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine	Orphenadrine Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine	Perphenazine The therapeutic efficacy of Perphenazine can be decreased when used in combination with Rasagiline.
Azathioprine	Azathioprine The metabolism of Rasagiline can be decreased when combined with Azathioprine.
Fluphenazine	Fluphenazine The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Rasagiline.
Phentermine	Phentermine Rasagiline may increase the hypertensive activities of Phentermine.
Methylphenidate	Methylphenidate Rasagiline may increase the hypertensive activities of Methylphenidate.
Amoxapine	Amoxapine The risk or severity of adverse effects can be increased when Rasagiline is combined with Amoxapine.
Sulfasalazine	Sulfasalazine Sulfasalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Phenazopyridine	Phenazopyridine Phenazopyridine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Carbamazepine	Carbamazepine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Rasagiline.
Molindone	Molindone The therapeutic efficacy of Molindone can be decreased when used in combination with Rasagiline.
Methyldopa	Methyldopa Rasagiline may decrease the hypotensive activities of Methyldopa.
Clonidine	Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Rasagiline.
Prazosin	Prazosin Rasagiline may increase the hypotensive activities of Prazosin.
Hydralazine	Hydralazine Rasagiline may increase the hypotensive activities of Hydralazine.
Cimetidine	Cimetidine Cimetidine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Gentamicin Injection	Gentamicin Injection Gentamicin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Warfarin	Warfarin Rasagiline may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam	Clonazepam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Clonazepam.
Promethazine	Promethazine The risk or severity of extrapyramidal symptoms can be increased when Promethazine is combined with Rasagiline.
Meclofenamate	Meclofenamate Meclofenamic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nitrofurantoin	Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Griseofulvin	Griseofulvin The metabolism of Rasagiline can be increased when combined with Griseofulvin.
Digoxin	Digoxin Rasagiline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine	Loxapine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Loxapine.
Chloroquine	Chloroquine Chloroquine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Quinine	Quinine The metabolism of Rasagiline can be decreased when combined with Quinine.
Ethosuximide	Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Rasagiline.
Triamterene	Triamterene Rasagiline may increase the orthostatic hypotensive activities of Triamterene.
Sulfinpyrazone	Sulfinpyrazone The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Sulfinpyrazone.
Chlorothiazide	Chlorothiazide Rasagiline may increase the hypotensive activities of Chlorothiazide.
Chlorthalidone	Chlorthalidone Rasagiline may increase the hypotensive activities of Chlorthalidone.
Metolazone	Metolazone Rasagiline may increase the hypotensive activities of Metolazone.
Isosorbide	Isosorbide Isosorbide may increase the excretion rate of Rasagiline which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital	Secobarbital Secobarbital may increase the hypotensive activities of Rasagiline.
Desipramine	Desipramine Rasagiline may increase the serotonergic activities of Desipramine.
Amitriptyline	Amitriptyline Rasagiline may increase the serotonergic activities of Amitriptyline.
Imipramine	Imipramine Rasagiline may increase the serotonergic activities of Imipramine.
Probenecid	Probenecid Probenecid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Quinidine	Quinidine The serum concentration of Rasagiline can be increased when it is combined with Quinidine.
Procainamide	Procainamide Rasagiline may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid	Isoniazid The metabolism of Rasagiline can be decreased when combined with Isoniazid.
Pyrazinamide	Pyrazinamide Pyrazinamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Rifampin	Rifampin The metabolism of Rasagiline can be increased when combined with Rifampicin.
Disopyramide	Disopyramide The metabolism of Rasagiline can be decreased when combined with Disopyramide.
Valproic Acid	Valproic Acid The metabolism of Rasagiline can be decreased when combined with Valproic acid.
Tamoxifen	Tamoxifen The metabolism of Rasagiline can be decreased when combined with Tamoxifen.
Butabarbital	Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Rasagiline.
Liothyronine	Liothyronine Liothyronine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Methimazole	Methimazole The metabolism of Rasagiline can be decreased when combined with Methimazole.
Chlorpropamide	Chlorpropamide Chlorpropamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tolbutamide	Tolbutamide Tolbutamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tolazamide	Tolazamide Tolazamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dextromethorphan	Dextromethorphan The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Dextromethorphan.
Cyclobenzaprine	Cyclobenzaprine Cyclobenzaprine may increase the serotonergic activities of Rasagiline.
Baclofen	Baclofen The risk or severity of hypotension can be increased when Baclofen is combined with Rasagiline.
Doxylamine	Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Cyproheptadine	Cyproheptadine Rasagiline may increase the anticholinergic activities of Cyproheptadine.
Clemastine	Clemastine Rasagiline may increase the anticholinergic activities of Clemastine.
Chlorpheniramine	Chlorpheniramine The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Rasagiline.
Brompheniramine	Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Rasagiline.
Meclizine	Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Rasagiline.
Ethambutol	Ethambutol Ethambutol may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Methyclothiazide	Methyclothiazide Rasagiline may increase the orthostatic hypotensive activities of Methyclothiazide.
Hydrochlorothiazide	Hydrochlorothiazide Rasagiline may increase the hypotensive activities of Hydrochlorothiazide.
Dantrolene	Dantrolene The risk or severity of adverse effects can be increased when Dantrolene is combined with Rasagiline.
Chlorzoxazone	Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Rasagiline.
Carisoprodol	Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Rasagiline.
Methocarbamol	Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Rasagiline.
Pyridoxine	Pyridoxine Pyridoxine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Folic Acid	Folic Acid Folic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) Rasagiline may increase the hypotensive activities of Propranolol.
Minoxidil	Minoxidil Rasagiline may increase the hypotensive activities of Minoxidil.
Pseudoephedrine	Pseudoephedrine Rasagiline may increase the hypertensive activities of Pseudoephedrine.
Nortriptyline	Nortriptyline Rasagiline may increase the serotonergic activities of Nortriptyline.
Spironolactone	Spironolactone Rasagiline may increase the orthostatic hypotensive activities of Spironolactone.
Amphotericin B Injection	Amphotericin B Injection Rasagiline may increase the orthostatic hypotensive activities of Amphotericin B.
Phytonadione	Phytonadione Phylloquinone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Amikacin Injection	Amikacin Injection Amikacin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nadolol	Nadolol Rasagiline may increase the hypotensive activities of Nadolol.
Butorphanol Injection	Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Rasagiline.
Nalbuphine Injection	Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Rasagiline.
Allopurinol	Allopurinol Allopurinol may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Trimethobenzamide	Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Rasagiline.
Flavoxate	Flavoxate Flavoxate may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Papaverine	Papaverine Rasagiline may increase the orthostatic hypotensive activities of Papaverine.
Fluorouracil Injection	Fluorouracil Injection The metabolism of Rasagiline can be decreased when combined with Fluorouracil.
Colchicine	Colchicine Rasagiline may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor	Cefaclor Cefaclor may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefadroxil	Cefadroxil Cefadroxil may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefazolin Injection	Cefazolin Injection Cefazolin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cephalexin	Cephalexin Cephalexin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefoxitin Injection	Cefoxitin Injection Cefoxitin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dacarbazine	Dacarbazine The metabolism of Rasagiline can be decreased when combined with Dacarbazine.
Acetazolamide	Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Rasagiline.
Cefotaxime Injection	Cefotaxime Injection Cefotaxime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Calcitonin Salmon Injection	Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ketoconazole	Ketoconazole The metabolism of Rasagiline can be decreased when combined with Ketoconazole.
Pyrantel	Pyrantel The risk or severity of adverse effects can be increased when Rasagiline is combined with Pyrantel.
Captopril	Captopril Rasagiline may increase the hypotensive activities of Captopril.
Dipyridamole	Dipyridamole Rasagiline may increase the orthostatic hypotensive activities of Dipyridamole.
Isoxsuprine	Isoxsuprine Rasagiline may increase the orthostatic hypotensive activities of Isoxsuprine.
Ethacrynic Acid	Ethacrynic Acid Rasagiline may increase the orthostatic hypotensive activities of Etacrynic acid.
Colistimethate Injection	Colistimethate Injection Colistimethate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Metoprolol	Metoprolol Rasagiline may increase the hypotensive activities of Metoprolol.
Hydroxyzine	Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Thiothixene	Thiothixene The therapeutic efficacy of Thiothixene can be decreased when used in combination with Rasagiline.
Aspirin	Aspirin Acetylsalicylic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Salsalate	Salsalate Salsalate may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Alprazolam	Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Rasagiline.
Temazepam	Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Rasagiline.
Triazolam	Triazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Rasagiline.
Dicyclomine	Dicyclomine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Hyoscyamine	Hyoscyamine Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline	Propantheline Propantheline may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Trimethoprim	Trimethoprim Trimethoprim may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Diltiazem	Diltiazem Rasagiline may increase the hypotensive activities of Diltiazem.
Nifedipine	Nifedipine Rasagiline may increase the orthostatic hypotensive activities of Nifedipine.
Timolol	Timolol Rasagiline may increase the hypotensive activities of Timolol.
Verapamil	Verapamil Rasagiline may increase the orthostatic hypotensive activities of Verapamil.
Atenolol	Atenolol Rasagiline may increase the hypotensive activities of Atenolol.
Pindolol	Pindolol The risk or severity of adverse effects can be increased when Pindolol is combined with Rasagiline.
Cisplatin Injection	Cisplatin Injection Rasagiline may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal	Diflunisal Diflunisal may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Piroxicam	Piroxicam Piroxicam may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Bumetanide	Bumetanide Rasagiline may increase the orthostatic hypotensive activities of Bumetanide.
Streptozocin	Streptozocin The metabolism of Rasagiline can be increased when combined with Streptozocin.
Etoposide	Etoposide The metabolism of Rasagiline can be decreased when combined with Etoposide.
Glyburide	Glyburide Rasagiline may increase the hypoglycemic activities of Glyburide.
Glipizide	Glipizide Glipizide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Indapamide	Indapamide Rasagiline may increase the hypotensive activities of Indapamide.
Amoxicillin	Amoxicillin Amoxicillin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nafcillin Injection	Nafcillin Injection The metabolism of Rasagiline can be increased when combined with Nafcillin.
Oxacillin Injection	Oxacillin Injection Oxacillin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Pentoxifylline	Pentoxifylline The risk or severity of bleeding and hemorrhage can be increased when Pentoxifylline is combined with Rasagiline.
Pentamidine Injection	Pentamidine Injection Pentamidine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ceftriaxone Injection	Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Labetalol	Labetalol Rasagiline may increase the hypotensive activities of Labetalol.
Auranofin	Auranofin Auranofin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Leuprolide Injection	Leuprolide Injection Leuprolide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Gemfibrozil	Gemfibrozil The metabolism of Rasagiline can be decreased when combined with Gemfibrozil.
Guanabenz	Guanabenz Rasagiline may increase the hypotensive activities of Guanabenz.
Dipivefrin Ophthalmic	Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ceftazidime Injection	Ceftazidime Injection Ceftazidime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ketoprofen	Ketoprofen Ketoprofen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefotetan Injection	Cefotetan Injection Cefotetan may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Pimozide	Pimozide The therapeutic efficacy of Pimozide can be decreased when used in combination with Rasagiline.
Enalapril	Enalapril Rasagiline may increase the hypotensive activities of Enalapril.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Amiodarone	Amiodarone Rasagiline may increase the orthostatic hypotensive activities of Amiodarone.
Aztreonam Injection	Aztreonam Injection Aztreonam may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Buspirone	Buspirone The risk or severity of hypertension can be increased when Rasagiline is combined with Buspirone.
Ciprofloxacin	Ciprofloxacin The serum concentration of Rasagiline can be increased when it is combined with Ciprofloxacin.
Mesalamine	Mesalamine Mesalazine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Diclofenac	Diclofenac Diclofenac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Fluoxetine	Fluoxetine The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Fluoxetine.
Nimodipine	Nimodipine Rasagiline may increase the hypotensive activities of Nimodipine.
Interferon Alfa-2b Injection	Interferon Alfa-2b Injection The metabolism of Rasagiline can be decreased when combined with Interferon alfa-2b.
Clozapine	Clozapine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Clozapine.
Estazolam	Estazolam The therapeutic efficacy of Rasagiline can be decreased when used in combination with Estazolam.
Ofloxacin	Ofloxacin The metabolism of Rasagiline can be decreased when combined with Ofloxacin.
Didanosine	Didanosine Didanosine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Pentostatin Injection	Pentostatin Injection Pentostatin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Benazepril	Benazepril Rasagiline may increase the hypotensive activities of Benazepril.
Etodolac	Etodolac Etodolac may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Felodipine	Felodipine Rasagiline may increase the hypotensive activities of Felodipine.
Fosinopril	Fosinopril Rasagiline may increase the hypotensive activities of Fosinopril.
Nabumetone	Nabumetone Nabumetone may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Quinapril	Quinapril Rasagiline may increase the hypotensive activities of Quinapril.
Ramipril	Ramipril Rasagiline may increase the hypotensive activities of Ramipril.
Amlodipine	Amlodipine Rasagiline may increase the hypotensive activities of Amlodipine.
Lisinopril	Lisinopril Rasagiline may increase the hypotensive activities of Lisinopril.
Oxaprozin	Oxaprozin Oxaprozin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sotalol	Sotalol Rasagiline may increase the orthostatic hypotensive activities of Sotalol.
Bisoprolol	Bisoprolol Rasagiline may increase the hypotensive activities of Bisoprolol.
Zolpidem	Zolpidem Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin	Doxazosin Rasagiline may increase the hypotensive activities of Doxazosin.
Terazosin	Terazosin Rasagiline may increase the hypotensive activities of Terazosin.
Isradipine	Isradipine Rasagiline may increase the hypotensive activities of Isradipine.
Omeprazole	Omeprazole The metabolism of Rasagiline can be increased when combined with Omeprazole.
Cisapride	Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Rasagiline.
Gabapentin	Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Rasagiline.
Venlafaxine	Venlafaxine Rasagiline may increase the serotonergic activities of Venlafaxine.
Fluvoxamine	Fluvoxamine The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.
Nefazodone	Nefazodone Rasagiline may increase the serotonergic activities of Nefazodone.
Lamotrigine	Lamotrigine The therapeutic efficacy of Rasagiline can be decreased when used in combination with Lamotrigine.
Losartan	Losartan Rasagiline may increase the hypotensive activities of Losartan.
Valacyclovir	Valacyclovir Valaciclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Tramadol	Tramadol The risk or severity of serotonin syndrome and seizure can be increased when Rasagiline is combined with Tramadol.
Carboplatin Injection	Carboplatin Injection Carboplatin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Moexipril	Moexipril Rasagiline may increase the hypotensive activities of Moexipril.
Ifosfamide Injection	Ifosfamide Injection Ifosfamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nicardipine	Nicardipine Rasagiline may increase the hypotensive activities of Nicardipine.
Bupropion	Bupropion The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.
Ticlopidine	Ticlopidine The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Ticlopidine.
Metformin	Metformin Metformin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Dalteparin Injection	Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Dalteparin.
Nisoldipine	Nisoldipine Rasagiline may increase the hypotensive activities of Nisoldipine.
Lamivudine	Lamivudine Lamivudine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Riluzole	Riluzole The metabolism of Rasagiline can be decreased when combined with Riluzole.
Amifostine Injection	Amifostine Injection Rasagiline may increase the orthostatic hypotensive activities of Amifostine.
Acarbose	Acarbose Acarbose may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Glimepiride	Glimepiride Rasagiline may increase the hypoglycemic activities of Glimepiride.
Gemcitabine Injection	Gemcitabine Injection Gemcitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Ritonavir	Ritonavir The metabolism of Rasagiline can be increased when combined with Ritonavir.
Cidofovir Injection	Cidofovir Injection Cidofovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Meropenem Injection	Meropenem Injection Meropenem may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Clomipramine	Clomipramine Rasagiline may increase the serotonergic activities of Clomipramine.
Zafirlukast	Zafirlukast The serum concentration of Rasagiline can be increased when it is combined with Zafirlukast.
Fosfomycin	Fosfomycin Fosfomycin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Mirtazapine	Mirtazapine Rasagiline may increase the serotonergic activities of Mirtazapine.
Trandolapril	Trandolapril Rasagiline may increase the hypotensive activities of Trandolapril.
Topiramate	Topiramate The therapeutic efficacy of Rasagiline can be decreased when used in combination with Topiramate.
Zileuton	Zileuton The metabolism of Rasagiline can be decreased when combined with Zileuton.
Valsartan	Valsartan Rasagiline may increase the hypotensive activities of Valsartan.
Insulin Lispro Injection	Insulin Lispro Injection The metabolism of Rasagiline can be increased when combined with Insulin lispro.
Pramipexole	Pramipexole Rasagiline may increase the sedative activities of Pramipexole.
Donepezil	Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Rasagiline.
Carvedilol	Carvedilol Rasagiline may increase the hypotensive activities of Carvedilol.
Nilutamide	Nilutamide Nilutamide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Flutamide	Flutamide The metabolism of Rasagiline can be decreased when combined with Flutamide.
Selegiline	Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Rasagiline.
Sertraline	Sertraline The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Sertraline.
Propafenone	Propafenone The metabolism of Rasagiline can be decreased when combined with Propafenone.
Irbesartan	Irbesartan Rasagiline may increase the hypotensive activities of Irbesartan.
Tamsulosin	Tamsulosin Rasagiline may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole	Ropinirole Rasagiline may increase the sedative activities of Ropinirole.
Finasteride	Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Rasagiline.
Quetiapine	Quetiapine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Cefepime Injection	Cefepime Injection Cefepime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefprozil	Cefprozil Cefprozil may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cefpodoxime	Cefpodoxime Cefpodoxime may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Cetirizine	Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Rasagiline.
Paroxetine	Paroxetine Rasagiline may increase the serotonergic activities of Paroxetine.
Tolcapone	Tolcapone Rasagiline may increase the orthostatic hypotensive activities of Tolcapone.
Citalopram	Citalopram The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Citalopram.
Capecitabine	Capecitabine Capecitabine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Efavirenz	Efavirenz The metabolism of Rasagiline can be decreased when combined with Efavirenz.
Abacavir	Abacavir Abacavir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sildenafil	Sildenafil The risk or severity of hypotension can be increased when Sildenafil is combined with Rasagiline.
Pioglitazone	Pioglitazone Rasagiline may increase the hypoglycemic activities of Pioglitazone.
Celecoxib	Celecoxib Celecoxib may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Rosiglitazone	Rosiglitazone The metabolism of Rasagiline can be decreased when combined with Rosiglitazone.
Tolterodine	Tolterodine Tolterodine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Thalidomide	Thalidomide Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir	Oseltamivir Oseltamivir may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Balsalazide	Balsalazide Balsalazide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Nateglinide	Nateglinide Nateglinide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Levetiracetam	Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Rasagiline.
Rabeprazole	Rabeprazole The metabolism of Rasagiline can be increased when combined with Rabeprazole.
Terbinafine	Terbinafine The metabolism of Rasagiline can be decreased when combined with Terbinafine.